Home › Heart Diseases › NCT07110922
Angiography and Electrogram Guided Bachmann Bundle Pacing
Angiography and Electrogram Guided Bachmann Bundle Pacing - ANGEL BBP
Who can join
Ages 18 and older · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: 1. Patients \> 18 years of age 2. Patient with an indication for permanent pacemaker or ICD utilizing atrial pacing lead 3. Patient is willing to comply with all study procedures and be available for the duration of the study. Exclusion Criteria: 1. Inability to provide informed consent 2. Pregnant 3. Enrolled in a concurrent study that may confound the results of this study. 4. Persistent atrial fibrillation at the time of implant (if cardioversion contraindicated at the time of implant, where BB mapping cannot be performed in sinus rhythm) 5. Renal dysfunction with serum Creatinine \>3.0 mg/dl
About the study
People eligible for this study are scheduled to have a permanent pacemaker (PPM) or defibrillator device (ICD) implanted as part of their routine care. This device will also have a wire placed in the right atrium (RA) of the heart. As an alternative to the RA, the wire can also be placed in the Bachmann bundle (BB).
This study is being done to compare two options to help place the wire in the Bachmann bundle. One option uses contrast dye and x-ray, and the other option uses electrocardiogram (ECG) and contrast dye and x-ray. We want to learn more about how well these options work in implanting the wire in the Bachmann bundle.
Both of these options are FDA approved and used in standard practice.
What is being tested
- Angiography only (diagnostic test)
- Angiography and ECG (diagnostic test)
Sponsor: Pugazhendhi Vijayaraman · Participants: 50 · Started: Aug 15, 2025
Contact the study team
- Pugazhendhi Vijayaraman, MD · Phone: 570-808-6020
Official record on ClinicalTrials.gov — NCT07110922
Locations in the U.S.
| Pennsylvania | Geisinger Wyoming Valley, Wilkes-Barre |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.